Objective: Approximately one third of patients diagnosed with muscle-invasive urinary
bladder cancer (UBC) have undetected metastases at the time of treatment of the primary …

Method: We include patients diagnosed with 3 types of urothelial tumours (prostate cancer,
urinary bladder cancer, and kidney cancer). A size-based separation method for viable CTC …

What's known on the subject? and What does the study add? Circulating tumour cells (CTC)
have prognostic relevance for patients with different metastatic carcinomas. Detection of …

Objective: To explore whether cultured CTC from bladder-cancer patients originate from
bladder cancer and share chromosomal abnormalities, by means of a fluorescence in situ …

Objectives: To evaluate the relationship between circulating tumor cells (CTC) and clinical
parameters in metastatic urothelial cancer (UC). Methods: CTC were enumerated with the …

Introduction The purpose of this study was to evaluate the impact of circulating tumor cells
(CTCs) as a prognostic marker in patients with high-risk non–muscle-invasive bladder …

Background Approximately 50% of patients with metastatic urothelial cancer (UC) respond
to chemotherapy and several months of therapy is required to assess for radiographic …

Objective To investigate circulating tumor cells (CTCs) as biomarkers of urothelial carcinoma
(UC). To date, the majority of work on this topic has utilized the CellSearch test, which has …

BACKGROUND. Circulating tumor cells (CTCs) have been shown to aid in the therapeutic
management of patients. But, only a few attempts have been made at the detection of …

High‐risk non‐muscle invasive bladder cancer (NMIBC) progresses to metastatic disease in
10–15% of cases, suggesting that micrometastases may be present at first diagnosis. The …